Technology ❯ Artificial Intelligence ❯ Investment Strategies

Stock Analysis

Pfizer–Trump Drug-Pricing Deal and ‘TrumpRx’ Plan Jolt Health-Care Stocks Higher

The agreement links Medicaid price cuts to a three-year tariff reprieve for Pfizer, signaling clearer policy direction.

Uranium Prices Top $80 as U.S. Policy Signals Drive Rally in Nuclear-Fuel Stocks